TLX
Telix Pharmaceuticals Limited American Depositary Shares

42
Mkt Cap
$2.97B
Volume
374,130.00
52W High
$20.00
52W Low
$6.28
PE Ratio
-414.69
TLX Fundamentals
Price
$8.75
Prev Close
$8.57
Open
$8.78
50D MA
$7.42
Beta
0.00
Avg. Volume
288,153.58
EPS (Annual)
-$0.0211
P/B
7.14
$2,855.96
Loading...
Loading...
News
all
press releases
Telix Pharmaceuticals Eyes 2026 Revenue Near $970M, Highlights PSMA Imaging Growth and Phase III Catalysts
Telix Pharmaceuticals (NASDAQ:TLX) executives highlighted commercial momentum in prostate cancer imaging and outlined multiple clinical programs in oncology during an H.C. Wainwright discussion featuring CEO Chris Behrenbruch and CMO David Cade. Company overview and 2026 revenue outlook Behrenbruch...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
What Powers BWXT's Strength in Nuclear Medicine Manufacturing?
BWX Technologies expands beyond defense, boosting nuclear medicine with isotopes, new capabilities and a growing role in cancer diagnostics and treatment.
Zacks·2d ago
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Trading Up 6.6% - Here's What Happened
Telix Pharmaceuticals (NASDAQ:TLX) Shares Up 6.6% - Time to Buy...
MarketBeat·5d ago
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Rating Lowered to Sell at Wall Street Zen
Wall Street Zen lowered shares of Telix Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Sunday...
MarketBeat·8d ago
News Placeholder
Portland Investment Counsel Inc. Takes $1.23 Million Position in Telix Pharmaceuticals Limited $TLX
Portland Investment Counsel Inc. purchased a new position in Telix Pharmaceuticals Limited (NASDAQ:TLX - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·9d ago
News Placeholder
Telix Pharmaceuticals Limited (NASDAQ:TLX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Telix Pharmaceuticals Limited (NASDAQ:TLX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine brokerages that are currently covering the stock, Marketbeat.com...
MarketBeat·11d ago
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Upgraded at Wall Street Zen
Wall Street Zen raised Telix Pharmaceuticals from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·16d ago
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Stock Price Up 5.5% - Time to Buy?
Telix Pharmaceuticals (NASDAQ:TLX) Shares Up 5.5% - What's Next...
MarketBeat·16d ago
News Placeholder
Telix Pharmaceuticals Highlights $1B Revenue Track, Pixclara Resubmission, PSMA Growth at Oppenheimer Conf.
Telix Pharmaceuticals (NASDAQ:TLX) outlined its commercial imaging franchise, regulatory plans for two radiodiagnostic candidates, and progress across a broad therapeutic radiopharmaceutical pipeline...
MarketBeat·21d ago
News Placeholder
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - Here's Why
Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up - What's Next...
MarketBeat·24d ago
<
1
2
...
>

Latest TLX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.